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A B S T R A C T
In this study the possible association between antibiotic use and resistance was explored, focusing on commensal
Escherichia coli from livestock (veal calves, young beef cattle, pigs and broiler chickens) in Belgium between
2011 and 2015. A continuous decreasing trend in antibiotic use was observed for all classes, except for the
phenicols. Antibiotic resistance of commensal E. coli signiﬁcantly decreased for several of the tested antibiotics
in all livestock species. A more rapidly reverted resistance was seen to 3th/4th generation cephalosporins and
ﬂuoroquinolones. Moderate to strong correlations between antibiotic use and resistance were found, except for
antibiotic resistance to chloramphenicol and gentamicin and the use of the corresponding antibiotic class. Yet,
total antibiotic use was positively correlated with chloramphenicol resistance, showing the potential importance
of co-selection for chloramphenicol resistance. These results suggest that national antimicrobial usage reduction
campaigns have beneﬁcial eﬀects on the overall resistance levels. Analyses were performed on small datasets,
though, and care must be taken while making inference. For more detailed analysis, antibiotic use data at an
animal species level are required.
1. Introduction
The use of antimicrobial agents lead to antimicrobial resistance in
bacteria from both animals and humans. Restrictive veterinary use is
currently introduced in several countries to reduce the selection and
spread of resistance in bacterial populations of animals (EPRUMA,
2017). Moreover, there are strong indications of animal–human trans-
mission of antimicrobial resistance, increasing the pressure towards a
reduced veterinary antimicrobial use (da Costa et al., 2013; Evers et al.,
2017). Today it is not fully understood to what extent restrictive use
eﬀects the levels of antimicrobial resistance. Furthermore, only long-
term monitoring might reveal robust changes in resistance patterns
(Speksnijder et al., 2014). In the Netherlands, along with a drop in total
sales of antimicrobials for veterinary use from 2007 onwards, reduced
resistance levels in commensal Escherichia coli in chickens, pigs, and
veal calves have been observed since 2010 (Dorado-Garcıa et al., 2016;
MARAN, 2016). A trend analysis of antimicrobial resistance based on
annual monitoring data can be used as objective measure to evaluate
the possible association with restrictive use. The Belgian policy on ve-
terinary antimicrobial use has set objectives for 2020, namely a 50%
lower total antimicrobial use, a 75% lower use of the most critical
antimicrobials and a 50% lower use of medicated feed by 2017, with
2011 as the reference year. Antimicrobial usage has dropped by 15.9%
between 2011 and 2015, by 6.4% for the most critical antimicrobials
and by 14.7% for the medicated feed (BelVet-SAC, 2016). Many eﬀorts
have been made to achieve these ﬁrst steps of reduction in anti-
microbial use and evidence of the positive impact of this reduced usage
might be a stimulant to persist on the antimicrobial reduction path.
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Moreover, a ﬁrst trend analysis of antimicrobial resistance in com-
mensal E. coli from several livestock species was performed in Belgium
for the period 2011 through 2014, based on data of the oﬃcial mon-
itoring programme (Hanon et al., 2015). The aim of this study was to
extend this ﬁrst trend analysis with more recent data from the national
resistance monitoring programme and to link this information with
data on the national veterinary antimicrobial consumption, collected
between 2011 and 2015 (BelVet-SAC, 2016) in order to asses to what
extent the observed trends are associated with each other.
2. Materials and methods
2.1. Study period
This study was based on annual data on antimicrobial use and re-
sistance, collected from 2011 to 2015, in the context of the Belgian
veterinary monitoring of antimicrobial consumption and antimicrobial
resistance (BelVet-SAC, 2016; CODA-CERVA, 2016).
2.2. Antimicrobial use data
The Veterinary Epidemiology Unit of the Faculty of Veterinary
Medicine from Ghent University collects and analyses under the au-
thority of the Federal Agency for Medicines and Health products the
veterinary antimicrobial consumption which is considered as all anti-
microbial substances sold yearly to a veterinarian, a pharmacist or
delivered in medicated feed in Belgium (BelVet-SAC, 2016). To eval-
uate this consumption in regard to the number of animals consuming it,
the consumption is divided by the biomass. The biomass (in kg) is, ac-
cording to Grave et al. (2010), the sum of the amount of beef, pork and
poultry meat produced yearly plus the number of dairy cattle present in
Belgium times 500 kg of metabolic weight per head. Animal population
data to calculate the produced biomass were derived from the Eurostat
website (Eurostat, 2017).
2.3. Antimicrobial resistance data
2.3.1. Sampling and laboratory testing
The Belgian monitoring programme of antimicrobial resistance was
performed in accordance with the EU decision 2013/652/EU and fol-
lowing European Food Safety Authority (EFSA) recommendations on
the harmonised monitoring and reporting of antimicrobial resistance in
E. coli (EFSA, 2014). Yearly, faecal samples are taken from 4 diﬀerent
livestock animal categories: veal calves, beef cattle, broiler chickens
and slaughter pigs, by oﬃcial veterinarians of the Federal Agency for
Safety of the Food Chain (FASFC) according to standardised technical
sampling instructions as part of the national monitoring programme.
Sampling and laboratory protocols are described in detail in Hanon
et al. (2015). The sample size was designed to reach a target of
minimum 170 Escherchia coli isolates per year for each livestock cate-
gory, following the EFSA recommendations (EFSA, 2008). The panel of
antimicrobials that were tested between 2011 and 2013 were ampi-
cillin, chloramphenicol, ciproﬂoxacin, colistin, ﬂorfeniciol, cefotaxime,
gentamicin, kanamycine, nalidixic acid, sulfamethoxazole, strepto-
mycin, ceftazidime, tetracycline and trimethoprim. This panel was
diﬀerent from the 2014 to 2015 antimicrobial panel, as the harmonised
monitoring at EU level became mandatory for E. coli in 2014. A new
panel of 14 antimicrobials, recommended by EFSA, was therefore
tested. Azithromycin, meropenem and tigecycline were added, whereas
other antimicrobials were removed (ﬂorfenicol, kanamycin and strep-
tomycin). To perform a trend analysis, at least 3 diﬀerent time points
have to be included (Hanon et al., 2015). Therefore, the trend analysis
was restricted to these antimicrobials for which data were available
since 2011 (11 out of the 14 antimicrobials). Minimum Inhibitory
Concentrations were determined by micro-dilution methods and an
isolate was identiﬁed as susceptible or resistant, based on the
epidemiological cut-oﬀ value (ECOFF) deﬁned by the European Com-
mittee of Antimicrobial Susceptibility Testing (EUCAST) (EUCAST,
2016). The ECOFFs were identical during the years included in the
trend analysis. The resistance percentage was calculated as the number
of resistant strains on the total number of tested strains per anti-
microbial substance and animal species (per year). Multi-resistance is
deﬁned as antimicrobial resistance of an isolate to at least three anti-
microbials of the panel, belonging to diﬀerent antimicrobial classes, as
deﬁned by Hanon et al. (2015).
2.4. Statistical analysis
2.4.1. Descriptive statistics
For each year, we estimated, according to Hanon et al. (2015), the
percentage of resistant and multi-resistant isolates and the weighted
entropy index for each speciﬁc antimicrobial, by livestock category.
The weighted entropy is a diversity index. Diversity indices are quan-
titative measures that reﬂect how many diﬀerent patterns of resistance
are present in a dataset, and simultaneously take into account how
evenly the observed resistance patterns in question are distributed. The
weighted entropy takes a higher value (closer to 1) if the isolates are
more distributed to the right end of the scale, i.e. resistant to a higher
number of antimicrobials (Hanon et al., 2015).
2.4.2. Relation between antimicrobial use and resistance
To analyse associations between use and resistance in the studied
time period (2011–2015) and in the absence of species-speciﬁc anti-
microbial use data, average resistance percentages (averaged over the
animal species) per active substance and levels of multi-resistance
(averaged over the animal species) were determined per year.
Antimicrobial usage data are presented per antimicrobial class, be-
cause, the selection pressure exerted by all substances belonging to one
class must be taken into account when investigating the link between
antimicrobial use and resistance to an antimicrobial substance (use in
mg antimicrobialclass = use in mg activesubstance1 + use in mg activesubstance2
+ use in mg activesubstance3 + …). The yearly antimicrobial use ﬁgures
per antimicrobial class are expressed against biomass as a yearly ad-
justed denominator according to the methodology described by Grave
et al. (2010). The total antimicrobial use (in mg) was calculated as the
sum of all classes used divided by the biomass (kg).
2.4.3. Consumption versus time
Using SAS 9.2 software (SAS Institute Inc., Cary, NC, USA), a Ken-
dall’s model was used to analyse the statistical correlation between the
ranking of two-by-two variables (consummation-years). Also, a linear
mixed model was ﬁtted with antimicrobial use per year per anti-
microbial class as outcome and year as predictor variable. Anti-
microbial class was included as random eﬀect to account for clustering
within antimicrobial classes. Year was included in the model, either as a
categorical or as a continuous variable. Following a likelihood ratio
test, linearity could be assumed (p=0.70). Model quality was veriﬁed
by exploring the normal probability plots of residuals and plots of re-
siduals versus predicted values.
2.4.4. Antimicrobial resistance trend analyses
Several statistical methods were tested to model the probability of
an isolate to be resistant, using SAS 9.2 software (SAS Institute Inc.,
Cary, NC, USA). Based on the results of Hanon et al. (2015), a linear
logistic regression model (univariate model where each antimicrobial
was considered separately) and a linear Generalized Estimating Equa-
tions (GEE) model (multivariate model taking into account the possible
correlation between antimicrobial substances in the time trend of re-
sistance) were used to analyse the time trend of resistance for each
antimicrobial separately. Adjusted p-values were calculated by applying
the Bonferroni correction and the linear step-up method of Benjamini
and Hochberg (1995) on the GEE model in order to take into account
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the multiple comparisons/testing performed in this study. For the
2011–2015 trend analyses, a non-linear logistic regression (univariate)
and a non-linear mixed model (multivariate) were added. The models
with the smallest Akaike information criterion (AIC) were selected and
presented in the results.
The results of the logistic regression are described in the form of
Odds Ratio (OR). An OR > 1 means that the probability to be resistant
increases with time whereas OR < 1 refers to a decreases over time.
2.4.5. Use versus resistance
2.4.5.1. Statistical correlations. Using SAS 9.2 software (SAS Institute
Inc., Cary, NC, USA), a Kendall’s model was used to analyse the
statistical correlation between the ranking of two-by-two variables
(antimicrobial use-resistance) for each antimicrobial substance or class
separately.
2.4.5.2. Logistic regression. The associations between antimicrobial use
and resistance were also examined by logistic regression models with
resistance (averaged over the animal species) considered as outcome
(grouped data) and use as a continuous predictor variable. Per active
substance, the antimicrobial use was ﬁrst expressed as the speciﬁc use
of the corresponding antimicrobial class and secondly the total use was
examined as the sum of all antimicrobial classes used. To obtain an
interpretable OR estimate, antimicrobial use was multiplied by 1000,
i.e. the unit was 1mg/1000 kg biomass. Additionally, the link between
multi-resistance and total antimicrobial use was examined in two ways.
Firstly, a grouped logistic regression was used to explore the relation
between the number of multi-resistant strains and the total
antimicrobial use per year. Secondly, the correlation between the
weighted entropy (averaged over the animal species) and the total
antimicrobial use was explored using Kendall’s correlation. Model
quality was veriﬁed by exploring the deviance residuals (logistic
regression).
3. Results
3.1. Annual antimicrobial use and resistance data
Trends in veterinary antimicrobial use and resistance over the study
period are presented in Figs. 1 and 2. Veterinary antimicrobial use
decreased by 15.9% between 2011 and 2015, except for ﬂorfenicols
(Fig. 2). Expressed in mg/kg biomass, the penicillins, potentiated sul-
phonamides and tetracyclines are the most used antimicrobial classes.
A total of 3912 E. coli isolates analysed for antimicrobial suscept-
ibility were included in the dataset. High prevalence (> 50%) of E. coli
resistant strains during the 5-year study period were observed for sev-
eral antimicrobials in all animal categories except beef cattle (Fig. 1,
Table 1). Highest antimicrobial resistance prevalence was observed for
the same substances in all animal species: ampicilin, sulfamethoxazole,
tetracycline and trimethoprim. Antimicrobial resistance to cipro-
ﬂoxacin and nalidixic acid reached the highest level in veal calves and
in broiler chickens in 2012, which later decreased in 2013/2014/2015
in these animal species. Lower levels were seen in beef cattle and pigs.
The resistance prevalence to 3rd generation cephalosporins (cefotaxime
and ceftazidime) was<5% during the whole study period for veal
calves, beef cattle and pigs, except in 2012 for veal calves and beef
cattle. For broilers, resistance to 3rd generation cephalosporins reached
highest levels in 2012, but decreased steadily towards levels of 4.6% for
both cefotaxime and ceftazidime in 2015.
3.2. Consumption versus time
Results of the Kendall’s correlation between antimicrobial use and
time showed that consumption tends to decrease over time for ‘total
use’ (Fig. 2l). This trend was clearly signiﬁcant for penicillins and tet-
racyclines (p < 0.05) and borderline signiﬁcant for polymyxins
(colistin) (p=0.05). Phenicols (ﬂorfenicol) was the only class for
which a continuous and signiﬁcant increase (p > 0.05) has been ob-
served over the 5 years study period (Fig. 2b).
The linear mixed model, including all antimicrobial classes in one
model, showed an overall signiﬁcant decrease in antimicrobial use over
time, regardless whether time was included as a categorical (p < 0.02)
or a continuous variable (p < 0.001). For antimicrobial class, a
random intercept was included in the model, since a random slope did
not improve the model signiﬁcantly (p=0.99).
3.3. Antimicrobial resistance and trend over time
Based on the AIC criterion, results of the non-linear multivariate
model were considered as ﬁnal results (Table 1). In veal calves, a sig-
niﬁcant decrease in antimicrobial resistance was found for all tested
antimicrobials except for gentamicin (10/11), in beef cattle for ampi-
cillin, ciproﬂoxacin, nalidixic acid, sulfamethoxazole, tetracycline and
trimethoprim (6/11), in broiler chickens for ampicillin, chlor-
amphenicol, ciproﬂoxacin, colistin, cefotaxime, nalidixic acid, sulfa-
methoxazole, ceftazidime, tetracycline and trimethoprim (10/11) and
in pigs for ampicillin, chloramphenicol, ciproﬂoxacin, cefotaxime, na-
lidixic acid, sulfamethoxazole, ceftazidime, tetracycline and trimetho-
prim (9/11). However, an increasing resistance trend was observed and
found signiﬁcant for gentamicin in beef cattle and in chickens (Table 1).
In broiler chickens, an increase in the annual resistance prevalence to
ciproﬂoxacin was clearly present between 2011 and 2012 (62.9% and
79.1% respectively). Despite a decrease in antimicrobial resistance in
2013 and 2014 (74.8% and 69.6% respectively), this resulted in a
signiﬁcant increasing trend between 2011 and 2014. By adding the
resistance prevalence of 2015 to the analysis (63.8%), this trend could
be reversed, and an overall decreasing trend in antimicrobial resistance
could be noticed again. The same pattern of an increase followed by a
decrease could be seen for chloramphenicol, colistin and nalidixic acid,
but, the signiﬁcant decrease in trend was already seen in 2014 and was
conﬁrmed in 2015.
3.4. Multi-resistance
The prevalence of multi-resistance was very high for broiler
chickens, which is the only animal species for which multi-resistance
increased in 2015, and high for veal calves during the 5 consecutive
years. Non-linear logistic regression showed a signiﬁcant continuous
decreasing trend since 2012 in veal calves and chickens and since 2013
in cattle and pigs (p < 0.05). Yet, for chickens, due to an increased
multi-resistance between 2014 and 2015, the overall decreasing trend is
only borderline signiﬁcant (95% conﬁdence interval with an upper
limit very close to 1) (Fig. 3). The values of the diversity index
(weighted entropy) decreased over time for all livestock species
(p < 0.05). The index is globally lower for pigs compared to other
species, meaning that for this species, multi-resistance to a high number
of antimicrobials is less frequent than for the others.
3.5. Consumption versus resistance
The Kendall’s model showed positive correlations between anti-
microbial resistance and the use of the corresponding antimicrobial
class during the study period for most antimicrobials, signiﬁcant for
ampicillin (p=0.01), and borderline signiﬁcant for colistin, sulfa-
methoxazole, trimethoprim and tetracycline (p=0.05). For chlor-
amphenicol (p=0.1) and gentamicin (p=0.3), the correlation is ne-
gative (Fig. 2). OR obtained from the logistic regression model are
higher than 1 and thus indicative for an increased probability for an E.
coli isolate to be resistant to the antimicrobials tested per increase in use
of 1mg of the corresponding antimicrobial class/1000 kg biomass, ex-
cept for gentamicin and chloramphenicol. For gentamicin, there is no
signiﬁcant association, while for chloramphenicol the association is
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clearly negative (Fig. 2).
Positive correlations were found between total antimicrobial use
and resistance, signiﬁcant for ampicillin (p=0.01) and borderline
signiﬁcant for ciproﬂoxacin, nalidixic acid, sulfamethoxazole, tetra-
cycline and trimethoprim (p=0.05). OR were higher than 1
(p < 0.001), except for colistin and gentamicin (Fig. 2).
A moderate to strong positive correlation between multi-resistance
(expressed as weighted entropy) and total antimicrobial use was no-
ticed (Kendall’s correlation coeﬃcient= 0.80; p=0.05).
4. Discussion
This study is the ﬁrst to report trends on veterinary antimicrobial
usage in Belgium, based on sales data, and to link this information with
antimicrobial resistance data. A decrease in veterinary antimicrobial
use was seen between 2011 and 2015, except for the phenicols. A lack
of data points made it impossible to analyse the consumption trend in
time per antimicrobial class (one data point per year) and therefore, all
classes were modelled in one analysis. Nevertheless, the assumption
that the same eﬀect for the diﬀerent antimicrobial classes could be
expected in time (checking for the need of a random slope per anti-
microbial class) with potentially diﬀerent consumption levels at the
start of the study period (2011) (random intercept per antimicrobial
class) was accepted in the model and a signiﬁcant decrease in time of
antimicrobial use was conﬁrmed. In Belgium, at present, antimicrobial
usage data are only available at the national level and not separated per
animal species, whereas a wide variation in the use of antimicrobials
between animal species has been observed (Fillipitzi et al., 2014).
Therefore, ideally, to have a better insight into the antimicrobial
exposure on the commensal E. coli population of food-producing ani-
mals, species speciﬁc data should be available. The mandatory regis-
tration of veterinary antimicrobial use at the farm level for veal calves,
pigs and poultry from February 2017 onwards in Belgium will meet the
requirements for more detailed and accurate data (Belgian Royal De-
cree of January 31, 2017). Farm level data on used doses, duration of
treatment and route of administration will allow to use a more appro-
priate indicator of antimicrobial consumption, i.e. the deﬁned daily
dose animal (DDDA) instead of milligrams of an active substance per
kilogram biomass and the complex association between antimicrobial
use and resistance will be further described and quantiﬁed (Bos et al.,
2013; Dupont et al., 2016; Collineau et al., 2017).
The antimicrobial resistance trend analysis of commensal E. coli
from food-producing animals in Belgium between 2011 and 2014 raised
some uncertainties on trends in resistance to certain antimicrobial
substances (Hanon et al., 2015). Particular attention was assigned to
critically important drugs for human and animal health, deﬁned by the
World Health Organization (WHO, 2011) and World Organization for
Animal Health (OIE, 2014). Hanon et al. (2015) reported that resistance
to (ﬂuoro)quinolones in broiler chickens was following a non-linear
path due to a decrease in 2013–2014, preceded by an increase in
2011–2012. By adding the 2015 data, the decreasing trend could be
conﬁrmed. In veal calves, however, the decrease in (ﬂuoro)quinolone
resistance since 2012 did not continue in 2015. On the contrary, a slight
increase (1.6%) was observed compared to 2014. This moderate in-
crease did not aﬀect the general decreasing trend of (ﬂuoro)quinolone
resistance in veal calves. Veterinary use of ﬂuoroquinolones ﬁrst de-
creased, but increased in 2015. Although it is not possible to identify
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Fig. 1. Average antimicrobial resistance prevalence of Escherichia coli in food-producing animals in Belgium between 2011 and 2015. AMP: ampicillin, CHL:
chloramphenicol, CIP: ciproﬂoxacin, COL: colistin, FOT: cefotaxime, GEN: gentamicin, NAL: nalidixic acid, SMX: sulfamethoxazole, TAZ: ceftazidime, TET: tetra-
cycline, TMP: trimethoprim.
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Fig. 2. Representation of veterinary antimicrobial use per class (a–k) and total (l) (mg active substance/kg biomass, left scale) in columns and the average anti-
microbial resistance prevalence of Escherichia coli in four food-producing animals (%, right scale) in line charts from 2011 to 2015. The Kendall’s π and p-values
assessing the possible correlation between antimicrobial resistance and (a) use of corresponding antimicrobial class, and (b) total antimicrobial use are presented.
Odds ratios (OR) and 95% Conﬁdence Interval (CI) associated with the probability for an E. coli isolate to be resistant to an antimicrobial tested per increase in use of
1 mg of (a) the corresponding antimicrobial class/1000 kg biomass or (b) the total antimicrobial use/1000 kg biomass for all animals in Belgium between 2011 and
2015. To obtain an OR estimate, antimicrobial use was multiplied by 1000, i.e. the unit was 1mg/1000 kg biomass.
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oﬃcial antimicrobial consumption data currently available, ﬂuor-
oquinolones are known to be used frequently in Belgian veal calves for
the treatment of diarrhoea (Pardon et al., 2012). It is expected that, as a
result of the legislative restriction policy on the use of 3rd and 4th
generation cephalosporins and ﬂuoroquinolones in food-producing
animals since August 2016, their use will decrease substantially. In
contrast to the previous analysis, non-linear models were used and were
shown to have the best ﬁt curves. Non-linear models take into account
the absence of a constant increase or decrease in antimicrobial re-
sistance per year. Raw antimicrobial resistance data indeed revealed no
constancy on this matter. Antimicrobial exposure is the main driver for
antimicrobial selection and spread. Yet, other factors than anti-
microbial use can be involved in the selection and spread of resistance
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Fig. 2. (continued)
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over time, as well as in other selecting factors may explain the non-
linearity in antimicrobial resistance prevalence over time. This study
conﬁrmed the decreasing trends for most antimicrobials, however the
decreasing trend between 2011 and 2014 slowed down in 2015, espe-
cially for veal calves and chickens. Furthermore, multi-resistance and
weighted entropy were conﬁrmed to decrease over time by the non-
linear model. Levels of multi-resistance and entropy are more dispersed
in bovines than in other animal species. This is indicative for a lower
number of multi-resistant E. coli strains, but being resistant to a higher
diversity of diﬀerent antimicrobials. This alerts for the emergence of
highly eﬃcient E. coli strains in terms of antimicrobial resistance. The
levels of antimicrobial resistance are still very high and particularly in
chickens for ampicillin, trimethoprim, sulfamethoxazole, ciproﬂoxacin
and nalidixic acid, and in veal calves for ampicillin, sulfamethoxazole
and tetracycline, showing resistance in more than half of the E. coli
strains during ﬁve consecutive years. The perpetuation of antimicrobial
resistance to penicillins, tetracyclines, trimethoprim and sulfonamides
is most likely due to their long drug use history and the implication of
multi-resistance patterns located on mobile genetic elements (BelVet-
SAC, 2016; Marchant et al., 2013; EFSA and ECDC, 2015). Exploring
the trend associating antimicrobial use and resistance is a highly de-
sirable exercise, because it helps to understand how antimicrobial re-
sistance is aﬀected by changes in antimicrobial use. A (borderline sig-
niﬁcant) positive association was found for most of the antimicrobials
tested in regard to the consumption of the corresponding antimicrobial
class or the total antimicrobial use by using correlation and logistic
regression models. The results obtained in this study are in line with the
results of an epidemiological ﬁeld study on antimicrobial use and re-
sistance in 7 European countries that showed signiﬁcant correlations
between antimicrobial use and resistance over all food-producing an-
imal species at the national level (Chantziaras et al., 2014). Ad-
ditionally, we intended to quantify the eﬀect of a decreased anti-
microbial use on the prevalence of resistance by using logistic
regression. Odds ratios are indicative for the probability of an E. coli
isolate to be resistant to an antimicrobial per increase or decrease in use
of 1mg of an antimicrobial of the corresponding antimicrobial class per
1000 kg biomass. It should be noted that the magnitude of the observed
odds ratios is linked to the amounts of consumption expressed in mgs of
an active substance per 1000 kg biomass. Estimates of odds ratios are
not comparable between antimicrobial classes for a given decrease of
consumption, as this measure of antimicrobial use does not reﬂect the
diﬀerent potencies of diﬀerent substances and therefore does not allow
for standardised comparison of usage between diﬀerent substances. For
example, for the same increase in use of a 3rd/4th generation cepha-
losporin (1mg/1000 kg biomass), a thousand times higher odds ratio
was observed for cefotaxime and ceftazidime compared to other anti-
microbials. Nevertheless, when looking at the relative change in anti-
microbial resistance for the diﬀerent substances, a much higher relative
decrease could be noticed for colistin, quinolones and cephalosporins.
The relation between antimicrobial use and resistance has been de-
scribed as a sigmoidal curve where a critical level of drug consumption
is required to trigger the increase of resistance to certain levels (Austin
et al., 1999). This also implies that small changes in the volumes of
antimicrobials, used in a population with a low level of antimicrobial
Table 1
Summary of the observed trends and of the persisting high prevalence of an-
timicrobial resistance for Escherichia coli isolates, per livestock category from
2011 till 2015. All indicated trends (↑, ↓) were statistically signiﬁcant
(p=0.05) in the non-linear multivariate model.
Antimicrobial substance veal calves beef cattle broiler chickens pigs
ampicillin ↓++ ↓ ↓++ ↓
chloramphenicol ↓ ↑↓ ↓
ciproﬂoxacin ↓ ↓ ↑↓++ ↓
colistin ↓ ↑↓
cefotaxime ↓ ↓ ↓
gentamicin ↑ ↑
nalidixic acid ↓ ↓ ↑↓++ ↓
sulfamethoxazole ↓++ ↓ ↓++ ↓+
ceftazidime ↓ ↓ ↓
tetracycline ↓++ ↓ ↓+ ↓+
trimethoprim ↓+ ↓ ↓++ ↓
++: Prevalence of antimicrobial resistance>50% during 5 consecutive years.
+: Prevalence of antimicrobial resistance > 40% during 5 consecutive years.
↑: Signiﬁcant increasing trend of antimicrobial resistance prevalence.
↓: Signiﬁcant decreasing trend of antimicrobial resistance prevalence.
↑↓: First increasing and then decreasing trend of resistance.
If no symbol is indicated for a corresponding antimicrobial and livestock ca-
tegory: no signiﬁcant trend and no persisting antimicrobial resistance> 40%
or>50% during the 5 consecutive years were observed.
Fig. 3. The prevalence and the 95%
Conﬁdence Interval of multi-resistant
Escherichia coli strains (=strains resistant to at
least three antimicrobials) (%, left scale); and
the weighted entropy (Index of diversity)
(right scale) for veal calves, beef cattle,
chickens and pigs between 2011 and 2015. The
higher the weighted entropy (closer to 1) in an
animal category for a certain year, the more
resistance to diﬀerent antimicrobial classes in
the corresponding Escherichia coli isolates.
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resistance, may lead to much larger changes in resistance when com-
pared to the eﬀect of comparable changes in use in a population where
already a high level of resistance is present (Austin et al., 1999; Handel
et al., 2006). This might equally imply that resistance to antimicrobials
with shorter usage history, i.e. quinolones and cephalosporins, could be
more rapidly reverted if a certain resistance level has not yet been es-
tablished (Dorado-Garcıa et al., 2016). This highlights the importance
of reacting on emerging resistance at the earliest possible phase. A
decreased use of the ﬂuoroquinolones was associated with a higher
odds ratio of an E. coli isolate to be susceptible to nalidixic acid
(OR=4.30, p=0.001) compared to ciproﬂoxacin (OR=3.78,
p=0.001). Development of resistance to ﬂuoroquinolones occurs
mainly by mutations (Strahilevitz et al., 2009) and the reduced ﬂuor-
oquinolone use between 2011 and 2015 likely resulted in less selection
of the resistant mutant subpopulation. The higher resistance percentage
to ciproﬂoxacin compared to nalidixic acid, though, conﬁrms other
resistance mechanisms are implicated and is indicative for the presence
of plasmid mediated quinolone resistance (PMQR) in the tested E. coli
strains (Strahilevitz et al., 2009).
In the Netherlands, total antimicrobial use reduction reached more
than 50% over 5 years (2009–2014). This has resulted in a substantial
reduction in resistance, though, associations clearly diﬀered between
animal sectors and antimicrobial substances (Dorado-Garcıa et al.,
2016). It might be expected that a further decrease in antimicrobial use
in Belgium, similarly as in the Netherlands, will result in a further re-
duction of antimicrobial (multi)-resistance.
The role of co-selection mechanisms in the persistence of anti-
microbial resistance was demonstrated by some associations showing a
greater eﬀect for total use than the use of the corresponding class.
Chloramphenicol for instance has been prohibited for veterinary use in
Europe since January 1997 (Council Regulation (EEC) 2377/90 and
amendments 1570/98 and 508/1999). Yet, antimicrobial resistance to
chloramphenicol is still present, although it tends to decrease. The
negative correlation between chloramphenicol resistance and phenicol
use in this study conﬁrms that cross-resistance with other phenicol
antimicrobials, authorized for veterinary use (e.g. ﬂorfenicol), is not an
explanation. Most of E. coli strains showing resistance to chlor-
amphenicol are not resistant to ﬂorfenicol, indicating that the me-
chanism involved relies on the persisting circulation of ‘old’ resistance
genes, which do not account for resistance to all phenicols (Schwarz
et al., 2004). Most likely, a decreased antimicrobial use prevented co-
selection of these old resistance genes and thus correspondingly re-
sulted in less chloramphenicol resistance.
5. Conclusions
Belgian policy measures on antimicrobial use have resulted in a
decreased veterinary antimicrobial use of all antimicrobial classes, ex-
cept ﬂorfenicols. Statistical evidence detects a coinciding decrease in
antimicrobial resistance for almost all antimicrobials, but the eﬀect was
most remarkable for the 3rd and 4th generation cephalosporins and
ﬂuoroquinolones. The role of co-selection in the persistence of re-
sistance has clearly been demonstrated for chloramphenicol. For more
detailed analysis, antibiotic use data at the animal species and farm
level are required.
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